These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31433905)

  • 21. A new technique using cultured epithelial sheets for the management of epistaxis associated with hereditary haemorrhagic telangiectasia.
    Milton CM; Shotton JC; Premachandran DJ; Woodward BM; Fabre JW; Sergeant RJ
    J Laryngol Otol; 1993 Jun; 107(6):510-3. PubMed ID: 8345299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Young's procedure for severe epistaxis from hereditary hemorrhagic telangiectasia.
    Richer SL; Geisthoff UW; Livada N; Ward PD; Johnson L; Mainka A; Henderson KJ; Maune S; White RI; Ross DA
    Am J Rhinol Allergy; 2012; 26(5):401-4. PubMed ID: 23168156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term results of dermatoplasty in the treatment of hereditary haemorrhagic telangiectasia.
    Ulsø C; Vase P; Stoksted P
    J Laryngol Otol; 1983 Mar; 97(3):223-6. PubMed ID: 6339655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The management of severe recurrent epistaxis due to hereditary hemorrhagic telangiectasia using regional facial cutaneous flaps.
    Strauss M; Zohar Y; Laurian N
    J Laryngol Otol; 1985 Apr; 99(4):373-7. PubMed ID: 4009036
    [No Abstract]   [Full Text] [Related]  

  • 25. The treatment of recurrent epistaxis due to hereditary haemorrhagic telangiectasia with intranasal bevacizumab.
    Alderman C; Corlett J; Cullis J
    Br J Haematol; 2013 Aug; 162(4):547-8. PubMed ID: 23672440
    [No Abstract]   [Full Text] [Related]  

  • 26. Surgical management of life-threatening epistaxis in Osler-Weber-Rendu disease.
    Rebeiz EE; Bryan DJ; Ehrlichman RJ; Shapshay SM
    Ann Plast Surg; 1995 Aug; 35(2):208-13. PubMed ID: 7486747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Endoscopic intranasal dermoplasty for the treatment of severe transfusion-dependent epistaxis in patients with hereditary hemorrhagic telangiectasia].
    He MQ; Liu YQ; Xu T
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Sep; 43(9):703-4. PubMed ID: 19035267
    [No Abstract]   [Full Text] [Related]  

  • 28. Argon plasma coagulation is an effective treatment for hereditary hemorrhagic telangiectasia patients with severe nosebleeds.
    Pagella F; Matti E; Chu F; Pusateri A; Tinelli C; Olivieri C; Canzonieri C; Boeri L; Ornati F; Danesino C
    Acta Otolaryngol; 2013 Feb; 133(2):174-80. PubMed ID: 23066781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficiency of laser treatment in patients with hereditary hemorrhagic telangiectasia.
    Jørgensen G; Lange B; Wanscher JH; Kjeldsen AD
    Eur Arch Otorhinolaryngol; 2011 Dec; 268(12):1765-70. PubMed ID: 21706320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of Hereditary Hemorrhagic Telangiectasia-Related Epistaxis.
    Sautter NB; Smith TL
    Otolaryngol Clin North Am; 2016 Jun; 49(3):639-54. PubMed ID: 27267016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical application of timolol decreases the severity and frequency of epistaxis in patients who have previously undergone nasal dermoplasty for hereditary hemorrhagic telangiectasia.
    Ichimura K; Kikuchi H; Imayoshi S; Dias MS
    Auris Nasus Larynx; 2016 Aug; 43(4):429-32. PubMed ID: 26739947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fiberoptic bronchoscope and Nd-YAG laser in treatment of severe epistaxis from nasal hereditary hemorrhagic telangectasia and hemangioma.
    Mehta AC; Livingston DR; Levine HL
    Chest; 1987 May; 91(5):791-2. PubMed ID: 3568789
    [No Abstract]   [Full Text] [Related]  

  • 33. Resurfacing the nasomaxillary cavity for management of epistaxis in Osler-Rendu-Weber disease.
    Bedongi A; McCombe D; Kennedy J; Morrison W
    J Plast Reconstr Aesthet Surg; 2006; 59(5):537-40; discussion 536. PubMed ID: 16749201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nasal closure for severe hereditary haemorrhagic telangiectasia in 100 patients. The Lund modification of the Young's procedure: a 22-year experience.
    Lund VJ; Darby Y; Rimmer J; Amin M; Husain S
    Rhinology; 2017 Jun; 55(2):135-141. PubMed ID: 28064338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are patients with severe epistaxis caused by hereditary hemorrhagic telangiectasia satisfied with nostril closure surgery?
    Ichimura K; Kikuchi H; Imayoshi S; Yamauchi T; Ishikawa K
    Auris Nasus Larynx; 2012 Feb; 39(1):59-64. PubMed ID: 21592697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hereditary hemorrhagic teleangiectasia--argon laser.
    Haye R; Austad J
    Rhinology; 1991 Mar; 29(1):5-9. PubMed ID: 2038655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: a double-blind, randomized, placebo-controlled trial.
    Riss D; Burian M; Wolf A; Kranebitter V; Kaider A; Arnoldner C
    Head Neck; 2015 Jun; 37(6):783-7. PubMed ID: 24595923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epistaxis in hereditary hemorrhagic telangiectasia: an evidence based review of surgical management.
    Chin CJ; Rotenberg BW; Witterick IJ
    J Otolaryngol Head Neck Surg; 2016 Jan; 45():3. PubMed ID: 26754744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Free-flap reconstruction for the management of life-threatening hereditary hemorrhagic telangiectasia.
    Choi JW; Joo YH; Jeong WS; Jang YJ
    Auris Nasus Larynx; 2017 Oct; 44(5):607-611. PubMed ID: 27616747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia.
    Mahoney EJ; Shapshay SM
    Am J Rhinol; 2006; 20(1):87-90. PubMed ID: 16539301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.